Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Astragaloside IV Mitigates Tacrolimus-Induced Chronic Nephrotoxicity by Regulating the mTOR-TFEB-GADD45alpha Pathway

Ping Gao, Xinwei Cheng, Rui Xu, Xinyu Huang, Jianqiao Wang, Maochang Liu, Xiuxun Wu, Xinlei Guan, Yunzhou Chen, Zhenpeng Qiu · 2026 · Journal of Agricultural and Food Chemistry · Atlas ID GAO2026

What this study shows

Astragaloside IV protects against tacrolimus-induced nephrotoxicity by inhibiting mTOR to activate TFEB and restore autophagy, nominating the mTOR-TFEB-GADD45alpha axis as a calcineurin-independent candidate therapeutic target (preclinical; no human data) in TICN.

Abstract

ShowHide

Tacrolimus-induced chronic nephrotoxicity (TICN) is mediated in part through calcineurin-dependent TFEB phosphorylation. Astragaloside IV (AS-IV) significantly reactivated TFEB and restored tacrolimus-impaired renal function, autophagy flux, and DNA repair. TFEB knockdown reversed AS-IV effects. AS-IV does not affect calcineurin but inhibits mTOR (which phosphorylates TFEB Ser211), thereby activating TFEB via the mTOR-TFEB-GADD45alpha axis.

Read the full abstract on PubMed →

At a glance

Evidence type M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: In vitro (renal cell lines)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is.
Study type5 - Mechanistic / In Vitro
Model systemIn vitro (renal cell lines)
JournalJournal of Agricultural and Food Chemistry
Year2026
Peer reviewedYes
Record last updated2026-07-29
SourceDOI 10.1021/acs.jafc.5c17921 · PMID 42438242

Extracted findings

InterventionAstragaloside IV
TargetmTOR / TFEB / GADD45alpha / autophagy
ModelIn vitro (renal cells)
EffectTFEB reactivation, restored autophagy flux, improved renal function markers, attenuation of nephrotoxicity

In the Atlas

Related topics

TFEBAstragaloside IVmTORGADD45alpha

More studies on this topic

Cite this paper

ShowHide
Ping Gao, Xinwei Cheng, Rui Xu, Xinyu Huang, Jianqiao Wang, Maochang Liu, Xiuxun Wu, Xinlei Guan, Yunzhou Chen, & Zhenpeng Qiu (2026). Astragaloside IV Mitigates Tacrolimus-Induced Chronic Nephrotoxicity by Regulating the mTOR-TFEB-GADD45alpha Pathway. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c17921

@article{GAO2026,
  author       = {Ping Gao and Xinwei Cheng and Rui Xu and Xinyu Huang and Jianqiao Wang and Maochang Liu and Xiuxun Wu and Xinlei Guan and Yunzhou Chen and Zhenpeng Qiu},
  title        = {{Astragaloside IV Mitigates Tacrolimus-Induced Chronic Nephrotoxicity by Regulating the mTOR-TFEB-GADD45alpha Pathway}},
  journal      = {Journal of Agricultural and Food Chemistry},
  year         = {2026},
  doi          = {10.1021/acs.jafc.5c17921},
  note         = {PMID: 42438242},
}

Cite this Atlas record

The record is the Atlas's own work — the evidence label, the extracted findings and the links. It is cited as part of the dataset, not as the paper.

Barton, O. (2026). Oliver's mTOR Atlas (record GAO2026) [Data set]. https://mtor-atlas.org/study/GAO2026/ · Dataset DOI 10.5281/zenodo.22059963

@misc{atlas_GAO2026,
  author       = {Barton, Oliver},
  title        = {{Oliver's mTOR Atlas}, record GAO2026},
  howpublished = {Data set},
  year         = {2026},
  url          = {https://mtor-atlas.org/study/GAO2026/},
  doi          = {10.5281/zenodo.22059963}
}